Haemonetics 1st Quarter Fiscal Year 2022 Earnings Release Available on Investor Relations Website

Go back to Haemonetics 1st Quarter Fiscal Year 2022 Earnings Release Available on Investor Relations Website

Haemonetics (HAE) Tops Q1 EPS by 4c

August 11, 2021 6:14 AM EDT

Haemonetics (NYSE: HAE) reported Q1 EPS of $0.50, $0.04 better than the analyst estimate of $0.46. Revenue for the quarter came in at $229 million versus the consensus estimate of $219.35 million.

GUIDANCE:

Haemonetics sees FY2022 EPS of $2.60-$3.00, versus the consensus of... More